Selected article for: "HLA class and SARS virus"

Author: Méndez-Sánchez, Nahum; Valencia-Rodríguez, Alejandro; Qi, Xingshun; Yoshida, Eric M.; Romero-Gómez, Manuel; George, Jacob; Eslam, Mohammed; Abenavoli, Ludovico; Xie, Weifen; Teschke, Rolf; Carrion, Andres F.; Keaveny, Andrew P.
Title: What Has the COVID-19 Pandemic Taught Us so Far? Addressing the Problem from a Hepatologist’s Perspective
  • Document date: 2020_4_11
  • ID: tiixwaqi_10
    Snippet: In the case of viral hepatitis, there is still no reliable information that supports synergism with SARS-CoV-2. However, it is known that SARS-CoV patients with viral hepatitis are more prone to develop liver damage and severe hepatitis. This was likely due to enhanced replication of the hepatitis virus during SARS-CoV infection. 20 In this context, some HLA class II haplotypes, like DRB1*1302, HLA-DR13, DQA1*0501, and DQB1*0301, have been relate.....
    Document: In the case of viral hepatitis, there is still no reliable information that supports synergism with SARS-CoV-2. However, it is known that SARS-CoV patients with viral hepatitis are more prone to develop liver damage and severe hepatitis. This was likely due to enhanced replication of the hepatitis virus during SARS-CoV infection. 20 In this context, some HLA class II haplotypes, like DRB1*1302, HLA-DR13, DQA1*0501, and DQB1*0301, have been related 2

    Search related documents:
    Co phrase search for related documents